Pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinolines: Novel compounds that reverse ABCG2-mediated resistance in cancer cells

Authors:

Abstract
No abstract available
Funding Information
  • University of Toledo (F110760)
  • Tuskegee RCMI Core (G12MD007585-23)
  • IBS-REU program and MSM/TU/UAB Comprehensive Cancer Center Partnership [NCI] (U54 CA118623)
  • Auburn University (101069-139268-2052)
  • Animal Health and Disease Research (101002-139268-2055)

This publication has 33 references indexed in Scilit: